CKD vs Thinksulin

This app is a clinical guide based upon the latest evidence available at the time of publication of the CKD Management in Primary Care 5th edition, 2024, Kidney Health Australia. The information is designed to provide health-care professionals with clinical actions, assist decision-making and be available at the click of a button on your personal device.  The CKD-Go! app includes a CKD staging calculator using eGFR and urine albumin:creatinine ratio data to identify clinical action plans relevant for the stage of CKD. Staging criteria is adapted from CKD Management in Primary Care 5th edition, all clinical action should consider an individual's circumstances.

Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2024); clinician and consumer consultations; and clinical expertise. Thinksulin aims to enhance the capacity and/or capability of junior medical officers and nursing staff responsible for prescribing and administering of insulin to patients in hospital with diabetes, although it can be used by any clinician responsible for the care of people in hospital with diabetes. Thinksulin is a point of care app that provides information and decision support on blood glucose level targets, hypoglycaemia management, blood glucose monitoring, basal-bolus calculations, and charting and reviewing doses.